Protocol summary
-
Study aim
-
Comparing of the results of primary endoscopic dacryocystorhinostomy surgery with and without silicon stenting in patients with epiphora
-
Design
-
Clinical trial with control group, with parallel group, double-blind, randomized on 72 patients.
-
Settings and conduct
-
72 patients who have referred to the department of AmirAl-Momenin hospital in Rasht with diagnosis of primary acquired lacrimal duct obstruction are randomly divided into 2 groups. Both groups will be operated on endoscopically by a specific surgeon.The first postoperative visit will take place in the first week and then in months 1st, 3th, 6th and 12th. All the studied outcomes are examined in all visits.The blinding method was such that during the study period, the surgeon and patients did not have access to random numbers in each block .
-
Participants/Inclusion and exclusion criteria
-
Inclusion Criteria: Patients 18 years of age and older with persistent epiphora or recurrent ocular discharge with primary diagnosis of acquired nasolacrimal duct obstruction.
Exclusion Criteria: previous history of nasolacrimal duct surgery؛ suspicion of lacrimal sac malignancy؛ canalicular obstruction requires membranectomy؛ presence of punctum and eyelid ectropion and facial nerve palsy and lid lag؛ history of radiotherapy and trauma and important disease in examined side of the nose and orbit؛ immunodeficiency and uncontrolled systemic diseases؛ congenital dacryocystitis؛ presence of abnormal bleeding disorders.
-
Intervention groups
-
The intervention group undergoing endoscopic DCR surgery with a stent and the control group undergoing endoscopic DCR surgery without a stent.
-
Main outcome variables
-
Improvement of symptoms; nasolacrimal duct and ostium opening; No dacryocystitis
General information
-
Reason for update
-
Due to the outbreak of the COVID-19 disease, the number of patients referred for DCR surgery decreased significantly, and due to the presence of the oculoplastic specialist, the number of patients referred to the ENT department decreased significantly. As a result, with the decision of the researchers, by changing the diagnostic accuracy of the study from 0.1 to 0.15, the sample size was reduced to 36 people in each group. This change was approved by the university's research committee.
-
Acronym
-
Dacryocystorhinostomy (DCR)
-
IRCT registration information
-
IRCT registration number:
IRCT20200718048126N1
Registration date:
2020-08-11, 1399/05/21
Registration timing:
prospective
Last update:
2024-08-03, 1403/05/13
Update count:
1
-
Registration date
-
2020-08-11, 1399/05/21
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2020-08-22, 1399/06/01
-
Expected recruitment end date
-
2022-08-23, 1401/06/01
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Comparing results of primary endoscopic Dacryocystorhinostomy (DCR) surgery with and without silicon stenting in patients with epiphora
-
Public title
-
Results of primary endoscopic Dacryocystorhinostomy surgery with and without silicon stenting in patients with epiphora
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Patients 18 years of age and older with persistent epiphora or recurrent ocular discharge with primary diagnosis of acquired nasolacrimal duct obstruction referred to Amir Al-Momenin hospital of Rasht
Exclusion criteria:
Previous history of nasolacrimal duct surgery, suspicion of lacrimal sac malignancy, canalicular obstruction requires membranectomy, presence of punctum and eyelid ectropion and facial nerve palsy and lid lag, history of Radiotherapy and trauma and important disease in examined side of the nose and orbit, immunodeficiencies and uncontrolled systemic disease, congenital dacryocystitis, presence of abnormal bleeding disorder
-
Age
-
From 18 years old
-
Gender
-
Both
-
Phase
-
N/A
-
Groups that have been masked
-
-
Sample size
-
Target sample size:
72
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
After obtaining the informed consent, the mentioned patients are randomly are divided into two groups with and without stenting for surgery. Block randomization method is used to divide patients using of PASS Software. Randomization is performed by a researcher who is not involved in the clinical stages of project. In this method, 72 patients are randomly divided into 9 blocks, with 4 patients in each block, of which 2 are operated with a stent and 2 without a stent. The order of placement of these 4 patients in each block Is also determined randomly. In cases of bilateral lacrimal duct obstruction, each eye is randomized separately. The first group will undergo endoscopic DCR surgery with a stent and second group will have no stent surgery by a specific surgeon. The blinding method was such that during the study, the surgeon and patients did not have access to random numbers in each block.
-
Blinding (investigator's opinion)
-
Double blinded
-
Blinding description
-
During the study period, the surgeon and patients did not have access to random numbers in each block . Also evaluation in months 1, 3, 6 and 12 by a resident who was unaware of allocation of individuals to the two groups.
-
Placebo
-
Not used
-
Assignment
-
Other
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2020-05-27, 1399/03/07
-
Ethics committee reference number
-
IR.GUMS.REC.1399.086
Health conditions studied
1
-
Description of health condition studied
-
Primary acquired nasoLacrimal duct obstruction
-
ICD-10 code
-
H04.55
-
ICD-10 code description
-
Acquired stenosis of nasolacrimal duct
Primary outcomes
1
-
Description
-
Improvement of symptoms; nasolacrimal duct and ostium opening in endoscopy; No dacryocystitis
-
Timepoint
-
Patients will be followed up for 12 months. The first postoperative visit will take place in the first week and then in the 1st, 3rd, 6th and 12th months. All the consequences studies are examined in the all Visits. If patients have a stent, it will be removed during the third month visit.
-
Method of measurement
-
The studied variables are examined by physical examination and nasal endoscopy in the first week after surgery and then 1st, 3rd, 6th and 12th months.
Intervention groups
1
-
Description
-
Intervention group: Patients undergoing endoscopic DCR surgery with stents placement
-
Category
-
Treatment - Surgery
2
-
Description
-
Control group: Patients undergoing endoscopic DCR surgery without stents placement
-
Category
-
Treatment - Surgery
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Rasht University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Yes - There is a plan to make this available
-
Study Protocol
-
Yes - There is a plan to make this available
-
Statistical Analysis Plan
-
Yes - There is a plan to make this available
-
Informed Consent Form
-
Yes - There is a plan to make this available
-
Clinical Study Report
-
Yes - There is a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available
-
Title and more details about the data/document
-
after the end of the study period
-
When the data will become available and for how long
-
after the end of the study period
-
To whom data/document is available
-
After the end of the study period, the results will be available to the public in the form of articles
-
Under which criteria data/document could be used
-
If published as an article
-
From where data/document is obtainable
-
ENT Research Center of Guilan University of Medical Sciences
-
What processes are involved for a request to access data/document
-
In-person referral or electronic request to the ENT Research Center of Guilan University of Medical Sciences
-
Comments
-